PRO-C3 was significantly elevated in the serum from patients with colorectal and pancreatic cancer, malignancies, known to have a deposition of fibrillar collagens [58,59,60], and a high PRO-C3 has previously been associated with mortality in cancer patients with a metastatic disease [19,61,62]. This evidence concerns the gene C3 and familial pancreatic carcinoma.